Daily oral administration of HOC in a nude mouse NEPC xenograft model markedly suppressed the tumor expression of EPHA3 and BRN2, along with their downstream effectors EZH2, ASCL1, and DLL3 and neuroendocrine markers SYP and CHGA. This evidence concerns the gene EPHA3 and neoplasm.